FDA scolds McKesson for naproxen in tampered oxycodone bottles, calling incidents ‘simply unacceptable’
The FDA found that McKesson responded inadequately and demonstrated a lack of understanding of key regulations, according to a Feb. 7 warning letter.
No hay comentarios:
Publicar un comentario